Astragaloside A
Supplier: SELLECK CHEMICALS LLC MS
Synonyms:
Astragaloside IV, (2R,3R,4S,5S,6R)-2-(((2aR,3R,4S,5aS,5bS,7S,7aR,9S,11aR,12aS)-4-Hydroxy-3-((2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-2a,5a,8,8-tetramethyl-9-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)hexadecahydrocyclopenta[a]cyclopropa[e]phenanthren-7-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
Astragaloside A (Astragaloside IV) is the primary pure saponin isolated from Astragalus membranaceus, which has been widely used for the treatment of cardiovascular diseases.
In in vitro condition the Astragaloside IV improves post-ischemic heart function and ameliorated reperfusion arrhythmias accompanied by a significant increase in myocardial antioxidative enzyme superoxide dismutase activity in rat hearts.
In in vivo they significantly reduces infarct size in dogs subjected to coronary ligation. Astragaloside IV attenuates isoproterenol-induced subendocardial necrosis, serum lactate dehydrogenase and creatine kinase activation, and lipid oxide product malondialdehyde formation in rats.
Formula:
C₄₁H₆₈O₁₄ MW: 784.970 g/mol |
MDL Number:
MFCD00210476 CAS Number: 83207-58-3 |
Learn more
![](/m-us.vwr.com/en_US/images/about_vwr_275x315.jpg)
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...